REFERENCES

1. Henneberg R: Die tierischen Parasiten des Zentralnervensystem.   In: Lewandowsky M, ed. Handbuch der Neurologie,  Berlin: Springer; 1912.

2. Mahajan RC: Geographical distribution of human cysticercosis.   In: Flisser A, Willms K, Laclette JP, et al ed. Cysticercosis. Present State of Knowledge and Perspectives,  New York: Academic Press; 1982.

3. Gajdusek DC: Introduction of Taenia solium into west New Guinea with a note on an epidemic of burns from cysticercus epilepsy in the Ekari people of the Wissel Lakes area. Papua New Guinea Med J  1978; 21(4):329-342.

4. Rabiela-Cervantes MT, Rivas-Hernandez A, Rodriguez-Ibarra J, et al: Anatomopathological aspects of human brain cysticercosis.   In: Flisser A, Willms K, Laclette JP, et al ed. Cysticercosis. Present State of Knowledge and Perspectives,  New York: Academic Press; 1982.

5. McGill RJ: Cysticercosis resembling myopathy. Lancet  1948; ii:728-730.

6. Medina MT, Rosas E, Rubio-Donnadieu F, et al: Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Int Med  1990; 150(2):325-327.

7. Chopra JS, Kaur U, Mahajan RC: Cysticerciasis and epilepsy: a clinical and serological study. Trans Roy Soc Trop Med Hyg  1981; 75(4):518-520.

8. van As AD, Joubert J: Neurocysticercosis in 578 black epileptic patients. S Afr Med J  1991; 80(7):327-328.

9. Forlenza OV, Filho AH, Nobrega JP, et al: Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychia  1997; 62(6):612-616.

10. Chandramuki A, Nayak P: Sub acute and chronic meningitis in children - an immunological study of cerebrospinal fluid. Indian J Pediatr  1990; 57(5):685-691.

11. Rangel R, Torres B, Del Bruto O, et al: Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg  1987; 36(2):387-392.

12. Chandy MJ, Rajshekhar V, Ghosh S, et al: Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiat  1991; 54(8):702-705.

13. Restrepo BI, Obregón-Henao A, Mesa M, et al: Characterization of the carbohydrate components of Taenia solium metacestode glycoprotein antigens. Int J Parasitol  2000; 30:689-696.

14. Bueno EC, Scheel CM, Vaz AJ, et al: Application of synthetic 8-kD and recombinant GP50 antigens in the diagnosis of neurocysticercosis by enzyme-linked immunosorbent assay. Am J Trop Med Hyg  2005; 72(3):278-283.

15. Espindola NM, Iha AH, Fernandes I, et al: Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatography. J Clin Microbiol  2005; 43(7):3178-3184.

16. Garcia HH, Parkhouse RM, Gilman RH, et al: Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans Roy Soc Trop Med Hyg  2000; 94(6):673-676.

17. Mason P, Houston S, Gwanzura L: Neurocysticercosis: experience with diagnosis by ELISA serology and computerised tomography in Zimbabwe. Cent Afr J Med  1992; 38(4):149-154.

18. do Amaral LL, Ferreira RM, da Rocha AJ, et al: Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging  2005; 16(2):127-144.

19. Sotelo J, Escobedo F, Rodriguez-Carbajal J, et al: Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med  1984; 310(16):1001-1007.

20. Mitchell WG, Crawford TO: Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics  1988; 82(1):76-82.

21. Lopez-Hernandez A, Garaizar C: Analysis of 89 cases of infantile cerebral cysticercosis.   In: Flisser A, Willms K, Laclette JP, et al ed. Cysticercosis. Present state of knowledge and perspectives,  New York: Academic Press; 1982.

22. Garcia HH, Evans CA, Nash TE, et al: Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev  2002; 15(4):747-756.

23. Del Brutto OH, Roos KL, Coffey CS, et al: Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med  2006; 145(1):43-51.

24. Sotelo J, Del Brutto OH, Penagos P, et al: Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol  1990; 237(2):69-72.

25. Corona T, Lugo R, Medina R, et al: Single-day praziquantel therapy for neurocysticercosis. N Engl J Med  1996; 334(2):125.

26. Allan JC, Velasquez-Tohom M, Fletes C, et al: Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans Roy Soc Trop Med Hyg  1997; 91(5):595-598.

27. Sciutto E, Morales J, Martinez JJ, et al: Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico. Parasitology  2007; 134(Pt 1):129-133.

28. Jung RC, Rodriguez MA, Beaver PC, et al: Racemose cysticercus in human brain. A case report. Am J Trop Med Hyg  1981; 30(3):620-624.

29. Lachberg S, Thompson RC, Lymbery AJ: A contribution to the etiology of racemose cysticercosis. J Parasitol  1990; 76(4):592-594.

30. Templeton AC: Anatomical and geographical location of human coenurus infection. Trop Geogr Med  1971; 23(1):105-108.

31. Ing MB, Schantz PM, Turner JA: Human coenurosis in North America: case reports and review. CID  1998; 27(3):519-523.

32. Maillard H, Marionneau J, Prophette B, et al: Taenia crassiceps cysticercosis and AIDS. AIDS  1998; 12(12):1551-1552.

33. Holodniy M, Almenoff J, Loutit J, et al: Cerebral sparganosis: case report and review. Rev Infect Dis  1991; 13(1):155-159.

34. Torres JR, Noya OO, Noya BA, et al: Treatment of proliferative sparganosis with mebendazole and praziquantel. Trans Roy Soc Trop Med Hyg  1981; 75(6):846-847.

35. Montenegro TC, Miranda EA, Gilman R: Production of monoclonal antibodies for the identification of the eggs of Taenia solium. Ann Trop Med Parasitol  1996; 90(2):145-155.

36. Allan JC, Velasquez-Tohom M, Torres-Alvarez R, et al: Field trial of the coproantigen-based diagnosis of Taenia solium taeniasis by enzyme-linked immunosorbent assay. Am J Trop Med Hyg  1996; 54(4):352-356.

37. Fan PC, Chung WC: Taenia saginata asiatica: epidemiology, infection, immunological and molecular studies. J Microbiol Immunol Infect  1998; 31(2):84-89.

38. Zarlenga DS, McManus DP, Fan PC, et al: Characterization and detection of a newly described Asian taeniid using cloned ribosomal DNA fragments and sequence amplification by the polymerase chain reaction. Experimental Parasitology  1991; 72(2):174-183.

39. Diaz CS, Candil RA, Uribe , et al: Serology as an indicator of Taenia solium tapeworm infections in a rural community in Mexico. Trans Roy Soc Trop Med Hyg  1990; 84(4):563-566.

40. Khalil HM, el Shimi S, Sarwat MA, et al: Recent study of Hymenolepis nana infection in Egyptian children. J Egypt Soc Parasitol  1991; 21(1):293-300.

41. Castillo RM, Grados P, Carcamo C, et al: Effect of treatment on serum antibody to Hymenolepis nana detected by enzyme-linked immunosorbent assay. J Clin Microbiol  1991; 29(2):413-414.

42. Ostling G: Treatment of tapeworm infection with desaspidin, a new phloroglucinol derivative isolated from Finnish fern. Am J Trop Med Hyg  1961; 10:855-858.

43. Curtis MA, Bylund G: Diphyllobothriasis: fish tapeworm disease in the circumpolar north. Arctic Med Res  1991; 50(1):18-24.

44. von Bonsdorff B: Diphyllobothriasis in man,  London, Academic Press, 1977.

45. Dupouy-Camet J, Peduzzi R: Current situation of human diphyllobothriasis in Europe. Euro Surveill  2004.31-35.